Skip to main content
. 2023 May 5;76(2):162–166. doi: 10.5173/ceju.2023.019

Table 5.

Progression data at 2-years of follow-up in the study groups

Site of reccurence / progression Combined organ-sparing management Radical nephroureterectomy Statistical evaluation
Upper tract reccurence 3 (9%) χ2 = 1.65;
р = 0.79
Bladder reccurence 3 (9%) 5 (15%)
Nodal metastases 4 (12%) 5 (15%)
Distant metastases 3 (9%) 4 (12%)
UTUC-associated death 3 (9%) 4 (12%)

UTUC – upper tract urothelial cancer